Curaleaf, a massive weed company out of Connecticut, is tired of playing nice. They want to buy their Canadian rival, Aurora Cannabis, but Aurora’s bosses keep slamming the door in their face. So, Curaleaf is going rogue. They are launching a “hostile takeover”—which basically means skipping the executives and taking their offer straight to the regular people who own Aurora’s stock.
The deal on the table is wild. Curaleaf is ready to drop $272 million to swallow Aurora whole. For every share of Aurora, a stockholder would get 75 cents in cold, hard cash plus a slice of Curaleaf stock, bringing the total value to about $4.00 a share. That’s a massive 45% bump over what the stock usually sells for. It’s an offer designed to make the shareholders turn against their own bosses.
This corporate brawl has been brewing all summer. Back in June, Curaleaf’s head honcho, Boris Jordan, sent a formal letter to Aurora’s CEO to try and make a friendly deal. Aurora basically ignored them. After a whole month of getting the silent treatment, Curaleaf decided they were done waiting. Now, they are filing official paperwork to bypass the boardroom entirely and take it to the streets.
Why go through all this trouble? Because if Curaleaf wins this fight, they will create an absolute monster in the global marijuana game.
We’re talking about a super-company spread across 17 different countries, pulling in over $1.5 billion a year in sales and making around $350 million in profit. Plus, combining the two businesses would save them a cool $40 million a year just by teaming up their massive growing operations in Europe and Canada.
It’s a high-stakes power grab, and now it’s up to Aurora’s shareholders to decide who wins.
Dabbin-Dad Newsroom
